Casgevy also now indicated for transfusion-dependent beta thalassemia in children 2 years ...

The clustered regularly interspaced short palindrome repeats (CRISPR) and Crispr-associated protein 9 (CRISPR/Cas9) is now a well-known, revolutionary method to engineer microbial cells. A key ...

A team of researchers led by Professor Akitsu Hotta (Department of Clinical Application) developed a comprehensive framework ...

Cas9 is directed to its target within the DNA sequence through the use of the guide RNA. A specific sequence of DNA that is between two and five nucleotides in length must align with the 3’ end of the ...

For several years now, the CRISPR/Cas9 gene scissors have been causing a sensation in science and medicine. This new tool of molecular biology has its origins in an ancient bacterial immune system. It ...

Researchers at Columbia University College of Dental Medicine have developed an exosome-based platform, "safeEXO-Cas," that significantly enhances the delivery of CRISPR/Cas9 genome editing components ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Innovative technologies such as the gene-editing tool CRISPR-Cas9 enable pioneering scientists to develop novel treatments for diseases such as cancer. A new study published in Science Translational ...

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.